Aesthetic Nursing
By Faisal Darwiche, NP — 2026-06-06
Exosomes are the most over-marketed thing in regenerative aesthetics right now, and the gap between what the marketing claims and what the regulation says is wide. I get asked about them constantly — "should I add exosomes to my menu?" — and the honest answer starts with a fact most courses skip: in the United States, exosomes are investigational and not FDA-approved for aesthetic or hair-restoration use. Here's the real picture, so you can make a decision with your eyes open instead of from a vendor's slide deck.
Exosomes are tiny vesicles released by cells that carry signaling molecules — proteins, lipids, and genetic material — that cells use to communicate with each other. In aesthetics, they're marketed as a way to deliver regenerative "signals" to the skin or scalp to support healing, collagen, and hair. The biology is genuinely interesting, and exosome research is active. But "interesting biology" and "a proven, approved aesthetic treatment" are not the same thing, and the distance between them is exactly where patients get oversold.
*This is general educational guidance, not a clinical protocol to apply without proper hands-on training and supervision.*
No. As of now, the FDA has not approved any exosome product for aesthetic or hair-restoration use — these applications are investigational. The agency has issued public safety warnings about unapproved regenerative products marketed directly to clinics and consumers, including products derived from stem cells and exosomes, and has cited contamination and serious adverse-event concerns in some cases. That doesn't mean the science is worthless; it means a clinic offering exosomes is offering an unapproved product, and that fact has to be represented honestly to every patient. If a vendor or course glosses over this, treat it as a warning about everything else they tell you.
Promising early signals, not settled proof. There's real laboratory and preliminary clinical interest in exosomes for skin and hair, and the mechanism is plausible. What there *isn't* yet is the body of large, rigorous, controlled human trials that would let anyone honestly call exosomes a proven aesthetic treatment. Product quality and concentration also vary widely between sources, which makes results hard to compare or reproduce. The honest framing for a patient is: this is an emerging, investigational treatment with encouraging biology and incomplete evidence — not a guaranteed result.
Exosome treatments sit at the premium end of the regenerative menu, because unlike PRP — which uses the patient's own blood — exosomes are a purchased, manufactured product, and that cost flows straight through to the price. An exosome facial commonly runs about $800 to $2,500 per session, meaningfully higher than a typical PRP session, which averages around $800. Prices vary widely by the source and brand of the product, so check current rates in your market. The more important point for a buyer: you're paying that premium for a product that is still investigational and unapproved for these uses, so the cost conversation and the regulatory conversation belong together.
No, and it's worth being clear because patients conflate them. Botox is an FDA-approved neurotoxin that temporarily relaxes a muscle to soften a dynamic wrinkle — a proven, approved, predictable treatment. Exosomes are an investigational, unapproved regenerative product meant to deliver cell signals to the skin or scalp. They don't do the same job, they don't share the same evidence base, and they don't share the same regulatory standing. "Are exosomes better than Botox?" is the wrong question — they aren't competitors. Botox is approved and treats movement; exosomes are investigational and aim at skin biology.
This is the real decision a nurse faces, because PRP and exosomes compete for the same regenerative slot. The short version: PRP is your own blood, autologous, with a longer track record and clearer regulatory standing; exosomes are externally sourced, investigational, and unapproved for these uses. For most nurses building a regenerative menu, PRP is the more defensible and reproducible foundation. Full comparison: PRP vs exosomes.
I'll give you the version I give my own patients: I don't endorse exosomes — or PRP, or stem cells — as a cure for hair loss. No regenerative product, however powerful the marketing, will regenerate follicles that are already gone. Some of these treatments may support a healthier scalp environment, but the "regrow your hair" framing oversells what the biology can do. A nurse trained well sets honest expectations; a nurse trained by a marketing deck repeats the hype and inherits the disappointed patient. Learn the science well enough to say what a treatment *can't* do.
Be cautious, and lead with the regulatory reality. Because exosomes are investigational and unapproved for these uses, adding them carries regulatory, liability, and trust exposure that approved treatments don't. If you're building a regenerative menu, the stronger foundation is the proven, more clearly-scoped work first — microneedling, PRP done with real concentration science, and biostimulators — before you reach for the newest, least-settled option. (See where to start building the menu for the sequence.) If you do explore exosomes, do it with full informed consent, accurate FDA representation, and your own counsel — not a vendor's compliance assurances.
*Typical results vary, and regenerative outcomes depend on the patient and the treatment. Nothing here is a guarantee of results, and exosome applications described are investigational.*
No. The FDA has not approved any exosome product for aesthetic or hair-restoration use — these applications are investigational. The agency has warned about unapproved regenerative products, including exosome- and stem-cell-derived ones. Any clinic offering exosomes must represent that honestly.
Tiny cell-released vesicles that carry signaling molecules cells use to communicate. In aesthetics they're marketed to deliver regenerative signals to skin and scalp. The biology is real and under active study, but the proof and approval that would make them a settled treatment aren't there yet.
The evidence is early and the marketing oversells it. No regenerative product regenerates follicles that are already gone. Some treatments may support a healthier scalp, but "regrow your hair" claims outrun the biology. Honest expectation-setting is part of competent practice.
PRP has a much longer clinical track record and clearer regulatory standing as an autologous product. Exosomes are externally-sourced, investigational, and unapproved for these uses. PRP is the more defensible and reproducible starting point for a regenerative menu.
Be cautious. Because they're investigational and unapproved for these uses, exosomes carry regulatory, liability, and trust exposure approved treatments don't. Build your menu on proven, clearly-scoped work first, and explore exosomes only with full informed consent and your own legal counsel.
The free 17-question assessment returns a state-specific 90-day launch plan: scope, entity, supplier sequence, and the exact next action for your scenario. 7 minutes. No card. Built by Faisal Darwiche, NP.
About the author
Faisal Darwiche, NP, is the founder of My Practice Academy. He's an AANP-certified nurse practitioner (MSN, adult-gerontology primary care) with 27+ years of clinical experience, a key opinion leader for leading aesthetic device companies, and faculty at The Aesthetic Show. He runs regenerative protocols in his own practices, has built and sold an aesthetics practice, currently operates three, and is published in the clinical literature. This article is general educational guidance, not legal or medical advice; confirm scope-of-practice and supervision requirements with your state board, verify the regulatory status of any product with current FDA guidance, and pursue proper hands-on training before performing any procedure.